Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD

British Journal of Nutrition

Volumn 107, Issue 6, 2012, Pages 921-927

  De Edelenyi, Fabien Szabo ^a   Vergnaud, Anne Claire ^a   Ahluwalia, Namanjeet ^a   Julia, Chantal ^a   Hercberg, Serge ^a,b   Blacher, Jacques ^a,c   Galan, Pilar ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Blood pressure; Folate; Hypertension; n 3 Fatty acids; Randomised controlled trials

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FACTORIAL DESIGN; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OVERWEIGHT; PATIENT COMPLIANCE; TETRAHYDROFOLATES; VITAMIN B COMPLEX;

EID: 84858763927     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511003692     Document Type: Article

References (35)

1. He FJ & MacGregor GA (2007) Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 22, 298-305. (Pubitemid 46897280)
2. MacMahon S, Peto R, Cutler J, et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335, 765-774. (Pubitemid 20106689)
3. Forman JP, Rimm EB, Stampfer MJ, et al. (2005) Folate intake and the risk of incident hypertension among US women. JAMA 293, 320-329. (Pubitemid 40116087)
4. Knapp HR (1991) Hypotensive effects of omega 3 fatty acids: mechanistic aspects. World Rev Nutr Diet 66, 313-328.
5. Geleijnse JM, Giltay EJ, Grobbee DE, et al. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20, 1493-1499. (Pubitemid 34921171)
6. Hooper L, Thompson RL, Harrison RA, et al. (2004) Omega 3 fatty acids for prevention and treatment of cardiovascular disease. The Cochrane Database of Systematic Reviews 2004 issue 4, CD003177.
7. McRae MP (2009) High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. J Chiropr Med 8, 15-24.
8. Toole JF, Malinow MR, Chambless LE, et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565-575. (Pubitemid 38500310)
9. van Dijk RA, Rauwerda JA, Steyn M, et al. (2001) Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 21, 2072-2079. (Pubitemid 34219764)
10. Appel LJ, Miller ER III, Seidler AJ, et al. (1993) Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153, 1429-1438. (Pubitemid 23191050)
11. Cicero AF, Ertek S & Borghi C (2009) Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 7, 330-337.
12. Mori TA & Woodman RJ (2006) The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9, 95-104. (Pubitemid 44090031)
13. Cagnacci A, Cannoletta M & Volpe A (2009) High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur J Clin Nutr 63, 1266-1268.
14. Mangoni AA, Sherwood RA, Swift CG, et al. (2002) Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 252, 497-503. (Pubitemid 36001992)
15. Papandreou D, Malindretos P, Arvanitidou M, et al. (2010) Homocysteine lowering with folic acid supplements in children: effects on blood pressure. Int J Food Sci Nutr 61, 11-17.
16. Williams C, Kingwell BA, Burke K, et al. (2005) Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 82, 26-31. (Pubitemid 41716373)
17. Nygard O, Vollset SE, Refsum H, et al. (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274, 1526-1533.
18. Kahleova R, Palyzova D, Zvara K, et al. (2002) Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens 15, 857-864. (Pubitemid 35168424)
19. Homocysteine Lowering Trialists' Collaboration (2005) Dosedependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806-812.
20. Galan P, Kesse-Guyot E, Czernichow S, et al. (2010) B-vitamins, n-3 polyunsaturated fatty acids and risk of cardiovascular events: the SU.FOL.OM3 trial. BMJ 341, c6273.
21. Morris MC, Sacks F & Rosner B (1993) Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523-533. (Pubitemid 23228051)
22. Tavazzi L, Maggioni AP, Marchioli R, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, doubleblind, placebo-controlled trial. Lancet 372, 1223-1230.
23. Ayer JG, Harmer JA, Xuan W, et al. (2009) Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 y. Am J Clin Nutr 90, 438-446.
24. Mayneris-Perxachs J, Bondia-Pons I, Serra-Majem L, et al. (2010) Long-chain n-3 fatty acids and classical cardiovascular disease risk factors among the Catalan population. Food Chem 119, 54-61.
25. Ishikawa Y, Yokoyama M, Saito Y, et al. (2010) Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J 74, 1451-1457.
26. Budge MM, de Jager C, Hogervorst E, et al. (2002) Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 50, 2014-2018. (Pubitemid 35462448)
27. Lim U & Cassano PA (2002) Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 156, 1105-1113. (Pubitemid 35453681)
28. Refsum H, Nurk E, Smith AD, et al. (2006) The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 136, 1731-1740.
29. Sutton-Tyrrell K, Bostom A, Selhub J, et al. (1997) High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 96, 1745-1749. (Pubitemid 27400728)
30. Dinavahi R, Cossrow N, Kushner H, et al. (2003) Plasma homocysteine concentration and blood pressure in young adult African Americans. Am J Hypertens 16, 767-770. (Pubitemid 37175993)
31. Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. (2005) Plasma homocysteine concentration and blood pressure in healthy Iranian adults: the Tehran Homocysteine Survey (2003-2004). J Hum Hypertens 19, 869-876. (Pubitemid 41637603)
32. Sundstrom J, Sullivan L, D'Agostino RB, et al. (2003) Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension 42, 1100-1105. (Pubitemid 37549062)
33. McMahon JA, Skeaff CM, Williams SM, et al. (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 137, 1183-1187. (Pubitemid 46701909)
34. Blacher J, Demuth K, Guerin AP, et al. (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18, 535-541. (Pubitemid 28177892)
35. Bortolotto LA, Safar ME, Billaud E, et al. (1999) Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 34, 837-842. (Pubitemid 29501309)